Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques

Her2/neu is an oncogene that plays an important role in the pathogenesis of many cancer types. In bladder carcinoma (BC), the clinical significance of Her2/neu status remains under-investigated and poorly linked to the patients’ clinic-pathological features and survival status.